Award

Evaluation of Emergency Department blood borne virus testing

NHS ENGLAND

This public procurement record has 1 release in its history.

Award

19 Jun 2023 at 08:51

Summary of the contracting process

The National Health Service (NHS) England recently concluded a procurement process for the evaluation of an Emergency Department blood borne virus testing project. The contracting authority, NHS England, in collaboration with UK Health Security Agency (UKHSA) and academic partners, conducted a comprehensive evaluation programme targeting HIV, Hepatitis B, and Hepatitis C testing. The procurement method used was a limited award procedure without prior publication of a call for competition. The contracting stage has been completed, and the award was made to UKHSA.

This tender presents an opportunity for businesses in the health services industry, particularly those involved in public health monitoring and evaluation, economic evaluation, and behavioural science research. Companies offering services related to surveillance of HIV and viral hepatitis would be well-suited to engage with the outcomes of this evaluation. The contract was signed on the 23rd of May 2023, opening avenues for collaboration and business growth in the healthcare sector.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Evaluation of Emergency Department blood borne virus testing

Notice Description

Evaluation of Emergency Department blood borne virus<br/>testing

Lot Information

Lot 1

The evaluation of the Emergency Department (ED) Blood borne virus (BBV) opt out testing project. As part of the Government's HIV Action Plan published in Dec 2021 the Government committed to provide PS20m of funding to NHS
England across three years to support the introduction of opt-out testing for HIV in 34 EDs in locations with the highest prevalence of HIV diagnosed.

This will support efforts to achieve the Government target of zero HIV transmissions in England by 2030. We have partnered with the NHSE Eliminating Hepatitis C programme team to include Hepatitis B and Hepatitis C testing in a BBV testing approach.

UKHSA and academic partners will undertake monitoring and evaluation to optimise the opt-out testing programme in terms of individual and public health benefits as well as value for money, a three-pronged evaluation approach is proposed: combining public health monitoring and evaluation, economic evaluation (collecting mainly quantitative data) as well as implementation optimisation / behavioural science research (collecting mainly qualitative data) to guide optimisation and standardisation and any
future roll-out of ED testing in lower prevalence sites.
Available demographic data on age, sex, ethnicity and deprivation (based on IMD of home address) will be used to investigate differences in testing and diagnosis to explore inequalities related to testing and accessing of treatment.
This analysis will support sites in targeting interventions (e.g. assertive outreach and increased use of peer support) at populations who are less likely to engage and maintain contact with treatment services, and thus align our work with CORE5PLUS aims.

This project has seen considerable early successes. External evaluation will ensure that we maximise the learning opportunities to inform clinical practice and BBV policy, and to demonstrate that this approach is both effective in reaching disadvantaged groups and cost effective.

Procurement Information

Criteria for STA: One economic operator due to exclusive rights, including intellectual property rights<br/><br/>Justification of STA Criteria and Reason: UKHSA is responsible for surveillance of HIV and viral hepatitis in England. This evaluation requires the matching of site level reported data with the national surveillance data, and UKHSA is the only organisation able to do this.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-03d74e
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/017280-2023
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
19 Jun 20232 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
22 May 20232 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Commercial Contract Manager
Contact Email
england.commercialqueries@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Post Town
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
1
Supplier Name

UK HEALTH SECURITY AGENCY (UKHSA

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-03d74e-2023-06-19T09:51:08+01:00",
    "date": "2023-06-19T09:51:08+01:00",
    "ocid": "ocds-h6vhtk-03d74e",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-03d74e",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Evaluation of Emergency Department blood borne virus testing",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85100000",
            "description": "Health services"
        },
        "mainProcurementCategory": "services",
        "description": "Evaluation of Emergency Department blood borne virus<br/>testing",
        "lots": [
            {
                "id": "1",
                "description": "The evaluation of the Emergency Department (ED) Blood borne virus (BBV) opt out testing project. As part of the Government's HIV Action Plan published in Dec 2021 the Government committed to provide PS20m of funding to NHS<br/>England across three years to support the introduction of opt-out testing for HIV in 34 EDs in locations with the highest prevalence of HIV diagnosed. <br/><br/>This will support efforts to achieve the Government target of zero HIV transmissions in England by 2030. We have partnered with the NHSE Eliminating Hepatitis C programme team to include Hepatitis B and Hepatitis C testing in a BBV testing approach.<br/><br/>UKHSA and academic partners will undertake monitoring and evaluation to optimise the opt-out testing programme in terms of individual and public health benefits as well as value for money, a three-pronged evaluation approach is proposed: combining public health monitoring and evaluation, economic evaluation (collecting mainly quantitative data) as well as implementation optimisation / behavioural science research (collecting mainly qualitative data) to guide optimisation and standardisation and any<br/>future roll-out of ED testing in lower prevalence sites.<br/>Available demographic data on age, sex, ethnicity and deprivation (based on IMD of home address) will be used to investigate differences in testing and diagnosis to explore inequalities related to testing and accessing of treatment. <br/>This analysis will support sites in targeting interventions (e.g. assertive outreach and increased use of peer support) at populations who are less likely to engage and maintain contact with treatment services, and thus align our work with CORE5PLUS aims.<br/><br/>This project has seen considerable early successes. External evaluation will ensure that we maximise the learning opportunities to inform clinical practice and BBV policy, and to demonstrate that this approach is both effective in reaching disadvantaged groups and cost effective.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "deliveryLocation": {
                    "description": "National"
                },
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "Criteria for STA: One economic operator due to exclusive rights, including intellectual property rights<br/><br/>Justification of STA Criteria and Reason: UKHSA is responsible for surveillance of HIV and viral hepatitis in England. This evaluation requires the matching of site level reported data with the national surveillance data, and UKHSA is the only organisation able to do this."
    },
    "awards": [
        {
            "id": "017280-2023-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-82555",
                    "name": "UK HEALTH SECURITY AGENCY (UKHSA)"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-67205",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "1st Floor, Quarry House, Quarry Hill",
                "locality": "Leeds",
                "region": "UKE",
                "postalCode": "LS2 7UE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Commercial Contract Manager",
                "email": "england.commercialqueries@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk//",
                "buyerProfile": "https://www.england.nhs.uk//",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "NATIONAL_AGENCY",
                        "description": "National or federal agency/office"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-82555",
            "name": "UK HEALTH SECURITY AGENCY (UKHSA)",
            "identifier": {
                "legalName": "UK HEALTH SECURITY AGENCY (UKHSA)"
            },
            "address": {
                "streetAddress": "3rd Floor, 2 Rivergate",
                "locality": "Bristol",
                "region": "UK",
                "postalCode": "BS1 6EH",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-1661",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "streetAddress": "The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody",
                "mediationBody"
            ],
            "details": {
                "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-67205",
        "name": "NHS England"
    },
    "contracts": [
        {
            "id": "017280-2023-1",
            "awardID": "017280-2023-1",
            "status": "active",
            "dateSigned": "2023-05-23T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "3",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            },
            {
                "id": "1",
                "measure": "lowestValidBidValue",
                "relatedLot": "1",
                "value": 400000,
                "currency": "GBP"
            },
            {
                "id": "2",
                "measure": "highestValidBidValue",
                "relatedLot": "1",
                "value": 400000,
                "currency": "GBP"
            }
        ]
    },
    "language": "en"
}